Comparative study of selective chromogenic (chromID VRE) and bile esculin agars for isolation and identification of vanB-containing vancomycin-resistant enterococci from feces and rectal swabs

Journal of Clinical Microbiology

Volumn 46, Issue 12, 2008, Pages 4034-4036

  Grabsch, Elizabeth ^a,c   Ghaly Derias, S ^a   Gao, W ^a   Howden, Benjamin ^a,b,c  

^a AUSTIN HEALTH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c AUSTIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; BILE ESCULIN AGAR; CHROMOGENIC AGAR; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FECES ANALYSIS; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CULTURE MEDIA; ENTEROCOCCUS; FECES; HUMANS; MICROBIAL SENSITIVITY TESTS; RECTUM; TIME FACTORS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 57349142977     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00944-08     Document Type: Article

References (18)

1. AB Biodisk. 2007. Etest application guide. M0000187 MH0245. AB Biodisk, Solna, Sweden.
2. Bell, J., J. Turnidge, G. Coombs, and F. O'Brien. 1998. Emergence and epidemiology of vancomycin-resistant enterococci in Australia. Commun. Dis. Intell. 22:249-252.
3. Bell, J. M., J. C. Paton, and J. Turnidge. 1998. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. J. Clin. Microbiol. 36:2187-2190.
4. Cetinkaya, Y., P. Falk, and C. G. Mayhall. 2000. Vancomycin-resistant enterococci. Clin. Microbiol. Rev. 13:686-707.
5. Delmas, J., F. Robin, C. Schweitzer, O. Lesens, and R. Bonnet. 2007. Evaluation of a new chromogenic medium, chromID VRE, for detection of vancomycin-resistant enterococci in stool samples and rectal swabs. J. Clin. Microbiol. 45:2731-2733.
6. Deshpande, L. M., T. R. Fritsche, G. J. Moet, D. J. Biedenbach, and R. N. Jones. 2007. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn. Microbiol. Infect. Dis. 58:163-170.
7. Dutka-Malen, S., S. Evers, and P. Courvalin. 1995. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol. 33:24-27.
8. Grabsch, E. A., K. Chua, S. Xie, J. Byrne, S. A. Ballard, P. B. Ward, and M. L. Grayson. 2008. Improved detection of vanB2-containing Enterococcus faecium with vancomycin susceptibility. J. Clin. Microbiol. 46:1961-1964.
9. Graham, M., S. A. Ballard, E. A. Grabsch, P. D. R. Johnson, and M. L. Grayson. 2008. High rates of fecal carriage of nonenterococcal vanB in both children and adults. Antimicrob. Agents Chemother. 52:1195-1197.
10. Lautenbach, E., W. B. Bilker, and P. J. Brennan. 1999. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect. Control Hosp. Epidemiol. 20:318-323.
11. Ledeboer, N. A., K. Das, M. Eveland, C. Roger-Dalbert, S. Mailler, S. Chatellier, and W. M. Dunne. 2007. Evaluation of a novel chromogenic agar medium for isolation and differentiation of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis isolates. J. Clin. Microbiol. 45:1556-1560.
12. Ledeboer, N. A., R. J. Tibbetts, and W. M. Dunne. 2007. A new chromogenic agar medium, chromID VRE, to screen for vancomycin-resistant Enterococcus faecium and Enterococcus faecalis. Diagn. Microbiol. Infect. Dis. 59:477-479.
13. Padiglione, A. A., R. Wolfe, E. A. Grabsch, D. Olden, S. Pearson, C. Franklin, D. Spelman, B. Mayall, P. D. R. Johnson, and M. L. Grayson. 2003. Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures. Antimicrob. Agents Chemother. 47:2492-2498.
14. Stamper, P. D., M. Cai, C. Lema, K. Eskey, and K. C. Carroll. 2007. Comparison of the BD GeneOhm VanR assay to culture for identification of vancomycin-resistant enterococci in rectal and stool specimens. J. Clin. Microbiol. 45:3360-3365.
15. Teixeira, L. M., M. S. Carvalho, and R. R. Facklam. 2007. Enterococcus, p. 430-442. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller (ed.). Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC.
16. Timmers, G. J., W. C. van der Zwet, I. M. Simoons-Smit, P. H. Savelkoul, H. H. Meester, C. M. J. E. Vandenbroucke-Grauls, and P. C. Huijgens. 2002. Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: risk factor assessment and successful control of the epidemic. Br. J. Haematol. 116:826-833.
17. Worth, L. J., K. A. Thursky, J. F. Seymour, and M. A. Slavin. 2007. Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur. J. Haematol. 79:226-233.
18. Young, H. L., S. A. Ballard, P. Roffey, and M. L. Grayson. 2007. Direct detection of vanB2 using Roche LightCycler vanA/B detection assay to indicate vancomycin-resistant enterococcal carriage - sensitive but not specific. J. Antimicrob. Chemother. 59:809-810.